Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation

Hematopoietic Cell Transplantation Clinical Trial

Official title: Development of Avatar-based Intervention to Support Patients Undergoing Reduced-Intensity Allogenic Stem Cell Transplantation

Status Completed

Clinical Trial Summary

The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.

Clinical Trial Description

This research study is a Pilot Study, which means the investigators are studying the application in a smaller group of people to understand whether the technology, care.coach, is easy to use.

This is a single site study at Dana-Farber Brigham and Women's Cancer Center.

• Aim 1 of the study will be an 8 - 10 participant focus group of nurses, navigator nurses, physicians, and NPs/PAs to refine the avatar protocols.

• Aim 2 of the study will be a pilot of 18 participants undergoing RIC allogeneic HCT in the hospital.

• The research study procedures include screening for eligibility, a brief call with a research assistant during use of care.coach avatar, and a survey after study completion.

• The avatar is designed to communicate with participants regarding transplantation education and provide reminders for eating, drinking, and activity.

• care.coach is a digital, avatar-based technology that communicates using natural speech software.

• care.coach is supporting this research by providing Dana-Farber access to its technology. The National Cancer Institute (NCI) also supports this research. ;

Related Conditions & MeSH terms

• Hematopoietic Cell Transplantation

• NCT number: NCT05600101
• Study type: Interventional
• Source: Dana-Farber Cancer Institute
• Status: Completed
• Phase: N/A
• Start date: November 1, 2022
• Completion date: May 16, 2023